Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-03-10 Sale | 2025-03-12 7:30 pm | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 2,235 | $0.615 | $1,375 | 2,233,310 (Direct) | View |
2025-03-10 Sale | 2025-03-12 7:28 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 2,360 | $0.615 | $1,451 | 605,346 (Indirect Direct) | View |
2025-03-10 Sale | 2025-03-12 7:27 pm | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 2,359 | $0.615 | $1,451 | 371,717 (Direct) | View |
2025-03-10 Sale | 2025-03-12 7:26 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 1,240 | $0.615 | $763 | 506,806 (Direct) | View |
2025-02-18 Sale | 2025-02-20 4:00 pm | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 34,712 | $0.783 | $27,179 | 1,192,545 (Direct) | View |
2025-02-03 Sale | 2025-02-05 5:31 pm | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 1,054 | $0.78 | $822 | 134,076 (Direct) | View |
2025-02-03 Sale | 2025-02-05 5:30 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 351 | $0.78 | $274 | 316,796 (Direct) | View |
2024-11-04 Sale | 2024-11-05 4:59 pm | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 1,033 | $1.227 | $1,267 | 135,130 (Direct) | View |
2024-11-04 Sale | 2024-11-05 4:59 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 283 | $1.227 | $347 | 317,147 (Direct) | View |
2024-09-12 Purchase | 2024-09-16 4:18 pm | Century Therapeutics Inc. | IPSC | Quimi Daphne Director | 5,000 | $1.5314 | $7,657 | 5,000 (Direct) | View |
2024-08-05 Sale | 2024-08-07 4:06 pm | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 1,073 | $1.827 | $1,960 | 136,163 (Direct) | View |
2024-08-05 Sale | 2024-08-07 4:06 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 289 | $1.827 | $528 | 334,041 (Direct) | View |
2024-07-26 Sale | 2024-07-31 09:08 am | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 586 | $2.5 | $1,465 | 367,706 (Indirect Direct) | View |
2024-07-23 Sale | 2024-07-25 5:04 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 1,800 | $2.5164 | $4,529 | 368,292 (Indirect Direct) | View |
2024-06-20 Sale | 2024-06-24 4:49 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 5,000 | $2.8357 | $14,179 | 370,092 (Indirect Direct) | View |
2024-06-05 Sale | 2024-06-06 4:53 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 5,000 | $2.9978 | $14,989 | 375,092 (Indirect Direct) | View |
2024-05-20 Sale | 2024-05-21 4:09 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 5,000 | $2.9955 | $14,978 | 380,092 (Indirect Direct) | View |
2024-05-06 Sale | 2024-05-07 5:13 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 5,000 | $3.1238 | $15,619 | 385,092 (Indirect Direct) | View |
2024-05-03 Sale | 2024-05-07 5:13 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 257 | $3.106 | $798 | 317,323 (Direct) | View |
2024-05-03 Sale | 2024-05-07 5:13 pm | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 913 | $3.106 | $2,836 | 137,236 (Direct) | View |
2024-04-22 Sale | 2024-04-24 4:17 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 5,000 | $3.0979 | $15,490 | 390,092 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-03-11 Option Award | 2025-03-12 7:31 pm | N/A 2035-03-11 | Century Therapeutics Inc. | IPSC | Conn Morgan Chief Finanical Officer | 19,500 | $0 | 99,148 (Direct) | View |
2025-03-11 Option Award | 2025-03-12 7:31 pm | N/A 2035-03-11 | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 19,500 | $0 | 260,503 (Direct) | View |
2025-03-11 Option Award | 2025-03-12 7:30 pm | N/A 2035-03-11 | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 521,500 | $0 | 2,233,310 (Direct) | View |
2025-03-11 Option Award | 2025-03-12 7:28 pm | N/A 2035-03-11 | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 120,000 | $0 | 605,346 (Direct) | View |
2025-03-11 Option Award | 2025-03-12 7:27 pm | N/A 2035-03-11 | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 120,000 | $0 | 371,717 (Direct) | View |
2025-03-11 Option Award | 2025-03-12 7:26 pm | N/A 2035-03-11 | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 95,625 | $0 | 506,806 (Direct) | View |
2024-12-04 Tax Withholding | 2024-12-06 4:57 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 243,447 | $1.44 | 1,227,257 (Direct) | View |
2024-11-01 Tax Withholding | 2024-11-05 4:59 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 16,611 | $1.26 | 317,147 (Direct) | View |
2024-10-14 Option Award | 2024-10-16 4:58 pm | N/A 2034-10-14 | Century Therapeutics Inc. | IPSC | Conn Morgan Chief Finanical Officer | 421,038 | $0 | 421,038 (Direct) | View |
Ownership | 2024-10-03 6:04 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 0 | $0 | 147,127 (Direct) | View |
2024-10-01 Option Award | 2024-10-03 6:04 pm | N/A 2034-10-01 | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 520,626 | $0 | 667,753 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:51 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | JIMENEZ JOSEPH Director | 44,000 | $0 | 44,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:51 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | Walbert Timothy P Director | 44,000 | $0 | 44,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:50 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | Quimi Daphne Director | 44,000 | $0 | 44,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:50 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | BUTITTA CYNTHIA M Director | 44,000 | $0 | 44,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:50 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | Riva Alessandro Director | 44,000 | $0 | 44,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:49 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | Carlo Rizzuto Director | 44,000 | $0 | 44,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:48 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director | 44,000 | $0 | 44,000 (Direct) | View |
2024-06-07 Option Award | 2024-06-10 4:36 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 17,007 | $0 | 334,330 (Direct) | View |
2024-03-07 Option Award | 2024-03-18 5:48 pm | N/A 2034-03-07 | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 121,975 | $0 | 1,575,254 (Direct) | View |
2024-03-07 Option Award | 2024-03-11 7:38 pm | N/A 2034-03-07 | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 95,000 | $0 | 398,580 (Direct) | View |
2024-03-07 Option Award | 2024-03-11 7:36 pm | N/A 2034-03-07 | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 170,000 | $0 | 541,092 (Direct) | View |
2024-03-07 Option Award | 2024-03-11 7:35 pm | N/A 2034-03-07 | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 170,000 | $0 | 284,149 (Direct) | View |